Patents Represented by Attorney, Agent or Law Firm Richard L. Neeley
  • Method and compositions for reducing neurotoxic injury
    Patent number: 4806543
    Abstract: A method for reducing adverse effects of neurotoxic injury, which comprises administering to a patient susceptible to neurotoxic injury an effective amount, sufficient to reduce the injury, of a compound which is an enantiomer of an analgesic opioid agonist or antagonist, preferably an opiate agonist having a ring system of the following stereochemistry, which shows only carbon and nitrogen atoms in the rings: ##STR1## The dextrorotatory opiates, dextrorphan and dextromethorphan, are particularly suitable for use in the method of the invention.
    Type: Grant
    Filed: November 25, 1986
    Date of Patent: February 21, 1989
    Assignee: Board of Trustees of the Leland Stanford Junior University
    Inventor: Dennis W. Choi
  • Method and composition for utilizing lime-urea hydrates to simultaneously reduce NO.sub.x and SO.sub.x in combustion effluents
    Patent number: 4795586
    Abstract: Methods and compositions are provided for simultaneous reduction of NO.sub.x and SO.sub.x in combustion effluents and process gas streams, exmploying a sorbent material of calcium or dolomitic lime hydrated with aqueous carboxamides, optionally with carbinol reductants, in amounts sufficient to reduce the NO.sub.x and SO.sub.x concentrations from the effluents. The sorbent material may be introduced as dry powders or wet hydrates in effluent streams at temperatures ranging from 400.degree. to 2400.degree. F.
    Type: Grant
    Filed: November 19, 1987
    Date of Patent: January 3, 1989
    Inventors: Richard E. Thompson, Lawrence J. Muzio
  • Therapeutic apheresis
    Patent number: 4643718
    Abstract: Disclosure is made of a means and method for removing immunologically reactive compounds from the blood of living mammals. The method of the invention comprises reacting the compound with an immunological homolog of the compound, bound to the surface of a lipid vesicle and thereafter separating the resulting complex from the blood plasma of the mammal.
    Type: Grant
    Filed: July 23, 1985
    Date of Patent: February 17, 1987
    Assignee: Applied Immunesciences, Inc.
    Inventor: James F. Marten
  • Pollen suppressant comprising a fused pyridazine
    Patent number: 4604134
    Abstract: Pollen suppressants of the formula ##STR1## wherein Z represents a divalent organic radical of the formula --CH.dbd.CH--CH.dbd.CH--, --CH.dbd.CH--CH.dbd.N--, --CH.dbd.CH--N.dbd.CH--, --CH.dbd.CH--NH--, --CH.dbd.CH--O--, or --CH.dbd.CH--S-- or said radical in which an H of Z is replaced with a halogen atom with the proviso that no more than three H or Z are replaced by fluorine; a C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkanoyl, cyano, nitro, hydroxy, or trihalomethyl group; or a group of the formula --NR.sup.1 R.sup.2 wherein R.sup.1 and R.sup.2 independently represent a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group; Y is Y.sup.1 R.sup.3 or NR.sup.4 R.sup.5 wherein Y.sup.1 is oxygen or sulfur; R.sup.3 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxyalkyl, cyclohexylmethyl, halogenated C.sub.1 -C.sub.4 alkyl, phenyl, or benzyl; and R.sup.4 and R.sup.5 are independently selected from the group consisting of hydrogen, C.sub.1 -C.sub.4 alkyl, or C.sub.1 -C.sub.
    Type: Grant
    Filed: September 14, 1983
    Date of Patent: August 5, 1986
    Assignee: Lafarge Coppee
    Inventors: Jeffrey N. Labovitz, Lawrence Fang